Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices
  • Print
  • Share
  • E-mail
-

GRN No. 1183

Monellin preparation produced by Komagataella phaffii P-MON-040 expressing a gene encoding for a modified monellin

Intended Use: Intended for use as a sweetener in foods generally at levels consistent with good manufacturing practices.
Basis: Scientific procedures
Notifier: Oobli, Inc.
Notifier Address: 202 Cousteau Place
Suite 210
Davis, CA 95618
GRAS Notice (releasable information): GRN 1183 with amendments (in PDF) (2.9 MB)
Date of closure: Nov 22, 2024
FDA's Letter: FDA has no questions (in PDF) (276 kB)
-
-